Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,598.69
(
-0.02%
)
US TECH 100
29,770.00
(
0.20%
)
Dow Jones
50,948.85
(
-0.25%
)
Brent Oil
94.60
(
-1.43%
)
Bitcoin
67,770.14
(
-5.04%
)
News Focus
News Focus
Post# of 257685
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123050
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 253543

Thursday, 06/26/2025 1:26:53 PM

Thursday, June 26, 2025 1:26:53 PM

Post# of 257685
ALT -55% on purportedly-positive phase-2b MASH data:

https://finance.yahoo.com/news/altimmune-announces-positive-topline-results-110000046.html

The effects on fibrosis improvement without worsening of MASH in an ITT analysis were 31.8% and 34.5% for pemvidutide 1.2 mg and 1.8 mg, respectively compared with 25.9% for placebo (differences not statistically significant).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today